Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
83 Cards in this Set
- Front
- Back
What is pharmacodynamics?
|
What a drug does in the body: biochemical, physiological, and behavioral effects of drugs
|
|
Mechanism of drug action is influenced by?
|
1. Structure-activity relationships
2. Receptors and signaling mechanisms |
|
What curve demonstrates the mechanism of drug action?
|
Dose-response curve
|
|
What is pharmacokinetics?
|
What the body does to a drug over time
|
|
Pharmacokinetics can also be defined as?
|
Quantitative study of the absorption, distribution, and clearance (metabolism and excretion) of drugs and drug metabolites
|
|
What determines the PLASMA DRUG CONCENTRATION (Cp)?
|
Absorption, distribution, and clearance at any time after drug administration
|
|
For many drugs, the intensity and duration of drug effects (therapeutic and toxic) are related to the?
|
Cp (plasma drug concentration)
|
|
What occurs to maintain therapeutic Cp and avoid toxic levels?
|
Selection and adjustment of drug dosage schedules
|
|
What determines Cp?
|
rate and extent of drug absorption
|
|
Oral administration is the?
|
safest and most comon route; also the most convenient and economical route
|
|
With oral administration where does the absorption mainly occur?
|
in the small intestine
|
|
Absorption of oral medications is usually demonstrated by this process?
|
first-order process
|
|
Controlled release medications demonstrate this process?
|
zero-order process
|
|
What are some disadvantages of oral adminstration?
|
irritation of GI tract; irregular absorption; inactivation of drug by enzymes, bacteria, low gastric pH, and FIRST-PASS ELIMINATION
|
|
First-pass elimination
|
drug in the venous blood leaving the GI tract is directed via the hepatic portal vein to the liver and some drugs which are avidly extracted by the liver may attain very low circulating levels after oral administration, compared to levels attained after parenteral administration
|
|
Bioavailability (F)
|
fraction of an orally (or parenterally) administered drug available to produce a pharmacological effect
|
|
Sublingual administration is useful for?
|
nonionized, highly lipid-soluble drugs (eg, nitro)
|
|
What are some benefits to sublingual administration?
|
rapid absorption and no first-pass elimination
|
|
Subcutaneous administration
|
provides for relatively slow and constant absorption and sustained therapeutic Cp; may minimize adverse drug effects
|
|
With subcutaneous administration, absorption is limited in part by?
|
blood flow to site of administration
|
|
Pulmonary administration
|
useful for gaseous and volatile agents and aerosols, rapid absorption
|
|
With pulmonary administration why is there rapid absorption?
|
1. Large alveolar surface area
2. Thin alveolar membranes 3. High rate of blood flow |
|
Name 3 other routes involving absorption
|
1. Intramuscular
2. Rectal 3. Transdermal |
|
Does intramuscular administration have a rapid or slow rate of absorption?
|
rapid
|
|
Rectal administration
|
some first-pass elimination may occur depending on location of drug in rectum
|
|
Transdermal
|
very slow absorption; prolonged duration of action
|
|
Intravenous administration
|
Technically does not involve absorption; F=100%
|
|
What are some benefits to IV administration?
|
1. Rapid and precise attainment of Cp
2. May be useful for administration of irritant drugs and solutions; drug is rapidly diluted |
|
What are some disadvantages of IV administration?
|
Increased risk of adverse effects (high Cp attained rapidly; possible toxicity, risk of embolism)
|
|
Compartment modeling
|
consider the body to be comprised of one or more compartments; each compartment represents a theoretical "space", not some actual anatomical region
|
|
Compartment modeling provides...
|
a mathematical description of drug disposition
|
|
One-compartment model
|
Conceptually simple, but not sufficient to describe the pharmacokinetic behavior of most drugs
|
|
Two-compartment model
|
Drug introduced via IV injection into a central compartment and eventual distribution of drug to peripheral compartment until equilibrium is reached btwn 2 compartments
|
|
What is included in the central compartment?
|
Intravascular fluid and highly perfused tissues such as the heart, brain, liver, kidneys, lungs and blood
|
|
These tissues in the central compartment make up only 10% of body mass, but receive what percentage of CO?
|
75% of resting CO
|
|
The lungs receive how much of the cardiac output of the right side of the heart?
|
100%
|
|
What tissues are included in the peripheral compartment?
|
tissues with lower perfusion rates, primarly muscle and fat (together ~ 70% of body mass)
|
|
Apparent volume of distribution (Vd)*
|
estimates the extent of distribution of a drug in the body
|
|
Vd=
|
Dose/Cp
|
|
Plasma concentration of the drug is at the point of?
|
distribution equilibrium C1=C2
|
|
Body compartment volumes
|
volume
compartment L/70kg L/kg TBW 42 0.6 ECF 14 0.2 Plasma 2.8 0.04 |
|
Plasma concentration-time curves plot?
|
the rate of change of Cp
|
|
With the plasma concentration-time curves there are two distinct phases, what are they?
|
1. Distribution (alpha) phase
2. Elimination (beta) phase |
|
Distribution (alpha) phase
|
begins immediately after IV injection of drug and represents distribution of drug from central compartment to peripheral compartment; EXPONENTIAL DECLINE in Cp (first-order process)
|
|
Elimination (beta) phase
|
1. Exponential decline in Cp (first-order kinetics)
2. Constant fraction of drug is eliminated from the central compartment per unit time (eg, 10% per hour) 3. Most drugs are eliminated from the central compartment by first-order kinetics |
|
Cp=
|
Ae(-alpha(t)) + Be (-beta(t))
|
|
alpha =
|
the distribution rate constant
|
|
beta=
|
the elimination rate constant, the SLOPE of the elimination phase of the curve
|
|
Use of the concentration-time curve to determine?
|
Vd
|
|
Protein binding of drugs
|
many drugs can bind to plasma proteins, and many are highly (>90%) protein-bound in the blood
|
|
Albumin binds mainly?
|
acidic drugs, such as barbituates
|
|
alpha1-acid glycoprotein (AAG) binds mainly?
|
basic drugs, such as local anesthetics
|
|
What exists between the bound and free drug fractions?
|
an equilibrium
|
|
What is the active fraction?
|
the free fraction
|
|
Vd is inversely related to?
|
the degree of plasma protein binding
|
|
Drug clearance may also be influenced by?
|
protein binding
|
|
Drugs may ______ with each other or with endogenous substances for protein binding sites.
|
compete
|
|
This competition may?
|
exaggerate of enhance the response of the drug
|
|
What causes decreased plasma proteins or with decreased binding affinity of plasma proteins for drugs?
|
some disease states such as liver disease or uremia (anything that reduces the amount of protein, eg, burns)
|
|
What may occur with decreased plasma proteins if a drug is normally highly protein bound (free fraction < 10%)?
|
May cause an exaggerated drug effect, though this may be of clinical significance only for rapidly acting drugs that are administered acutely (eg, versed)
|
|
What may occur with decreased plasma proteins if a drug is only moderately protein bound?
|
changes in protein binding will likely be clinically unimportant, even for rapidly acting drugs; for example, if the free fractionof a drug increases from 50-60% for a particular drug dose, the plasma concentration of free drug will increase at most by 1/5 or 20%, which will likely be clinically insignificant
|
|
Drug clearance
|
the ratio of the rate of drug eliminated by all routes to the plasma drug concentration
|
|
CL=
|
rate of elimination/Cp
|
|
What are the units of CL?
|
volume per time (min/mL)
|
|
What are the two main sites of drug elimination?
|
liver and kidneys; other sites include the lung and blood
|
|
hepatic clearance
|
biotransformation and/or excretion of unchanged drug in the bile
|
|
renal clearance
|
excretion of unchanged drug in the urine
|
|
For most drugs, clearance is a _____ process?
|
first order process
|
|
In first order process, rate of elimination is proportional to?
|
amount of drug present
|
|
CL is independent of?
|
drug dose
|
|
As Cp increases, so does the?
|
rate of elimination
|
|
CL is not?
|
saturable over the range of therapeutic plasma levels
|
|
For some drugs, clearance is?
|
capacity-limited
|
|
Synonyms to capacity-limited.
|
zero-order process; dose-dependent clearance; nonlinear kinetics
|
|
CL does depend on?
|
dose (rate of elimination stays constant despite an increase in Cp)
|
|
elimination pathways are?
|
saturable
|
|
T or F. in capacity-limited clearance a constant amount of drug is eliminated per unit time.
|
True
|
|
What are some examples of drugs that undergo zero-order kinetics of elimination?
|
ethanol, ASA, phenytoin
|
|
Elimination half-time, t1/2 (plasma half-life)
|
amount of time necessary for Cp to fall by 50%; estimate of the rate of elimination of the drug by the body
|
|
For a first-order process: t1/2 =
|
0.69/beta, where beta=elimination rate constant (fraction of drug eliminated per hour)
|
|
t1/2=
|
0.69 x Vd/CL
|
|
How many half-times are necessary for almost complete elimination of a drug (~97%)?
|
5 times
|
|
Where is t1/2 most useful?
|
in the design of drug dosage schedules
|